Format
Sort by

Send to

Choose Destination

Search results

Items: 2

1.

The CRISPR/Cas9 system efficiently reverts the tumorigenic ability of BCR/ABL in vitro and in a xenograft model of chronic myeloid leukemia.

García-Tuñón I, Hernández-Sánchez M, Ordoñez JL, Alonso-Pérez V, Álamo-Quijada M, Benito R, Guerrero C, Hernández-Rivas JM, Sánchez-Martín M.

Oncotarget. 2017 Apr 18;8(16):26027-26040. doi: 10.18632/oncotarget.15215.

2.

Preparation and characterization of triclosan nanoparticles for periodontal treatment.

Piñón-Segundo E, Ganem-Quintanar A, Alonso-Pérez V, Quintanar-Guerrero D.

Int J Pharm. 2005 Apr 27;294(1-2):217-32.

PMID:
15814246

Supplemental Content

Loading ...
Support Center